[{"address1": "National Innovation Centre", "address2": "Suite 212a 2 4 Cornwallis Street Eveleigh", "city": "Sydney", "state": "NSW", "zip": "2015", "country": "Australia", "phone": "61 2 9209 4037", "fax": "61 2 9209 4037", "website": "https://www.claritypharmaceuticals.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. Clarity Pharmaceuticals Ltd was incorporated in 2010 and is based in Sydney, Australia.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan John Taylor Ph.D.", "title": "Executive Chairman", "fiscalYear": 2023, "totalPay": 566373, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Colin David Biggin Ph.D.", "title": "MD, CEO & Executive Director", "fiscalYear": 2023, "totalPay": 454100, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Green BEc., CA", "title": "Chief Financial Officer", "fiscalYear": 2023, "totalPay": 158947, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shaemus  Gleason", "title": "Executive Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew  Harris BSc., M.B.A., Ph.D.", "title": "CTO & Director of Technology", "fiscalYear": 2023, "totalPay": 130627, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey  Norenberg", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Michelle  Parker", "title": "Executive Vice President of Global Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Vickery", "title": "Company Secretary", "fiscalYear": 2023, "totalPay": 109015, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.48, "open": 3.73, "dayLow": 3.73, "dayHigh": 3.73, "regularMarketPreviousClose": 3.48, "regularMarketOpen": 3.73, "regularMarketDayLow": 3.73, "regularMarketDayHigh": 3.73, "beta": 1.548, "volume": 1200, "regularMarketVolume": 1200, "averageVolume": 11216, "averageVolume10days": 9658, "averageDailyVolume10Day": 9658, "bid": 3.41, "ask": 3.75, "bidSize": 40000, "askSize": 40000, "marketCap": 1162439680, "fiftyTwoWeekLow": 0.503, "fiftyTwoWeekHigh": 3.75, "priceToSalesTrailing12Months": 122.5403, "fiftyDayAverage": 2.874908, "twoHundredDayAverage": 1.7145022, "currency": "USD", "enterpriseValue": 940171584, "floatShares": 179214672, "sharesOutstanding": 311646016, "heldPercentInsiders": 0.29373, "heldPercentInstitutions": 0.06712, "impliedSharesOutstanding": 314956000, "bookValue": 0.202, "priceToBook": 18.465345, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -30562508, "trailingEps": -0.08, "enterpriseToRevenue": 99.11, "enterpriseToEbitda": -28.819, "52WeekChange": 6.3861384, "SandP52WeekChange": 0.22553468, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "CLRPF", "underlyingSymbol": "CLRPF", "shortName": "CLARITY PHARMACEUTICALS LTD", "longName": "Clarity Pharmaceuticals Ltd", "firstTradeDateEpochUtc": 1677508200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e3adc917-5183-3806-b4b8-3bebee6c5494", "messageBoardId": "finmb_263530964", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.73, "recommendationKey": "none", "totalCash": 37982804, "totalCashPerShare": 0.145, "ebitda": -32623064, "quickRatio": 10.905, "currentRatio": 11.762, "totalRevenue": 9486183, "revenuePerShare": 0.036, "returnOnAssets": -0.27666, "returnOnEquity": -0.45330003, "freeCashflow": -28502352, "operatingCashflow": -37663704, "revenueGrowth": -0.055, "grossMargins": 1.0, "operatingMargins": -3.3585901, "financialCurrency": "AUD", "trailingPegRatio": null, "__fetch_time": "2024-06-30"}]